Target intelligence / Profile preview

Hyaluronic acid extracellular matrix interaction (HA-ECM interaction)

Target
HA-ECM interaction
Molecular classification
Extracellular matrix interaction, Cell-matrix interaction, Glycosaminoglycan-mediated process, Receptor-ligand interaction system
01

Overview

Hyaluronic acid extracellular matrix interaction refers to the complex biological process through which hyaluronan (HA), a non-sulfated glycosaminoglycan composed of repeating disaccharides of D-glucuronic acid and N-acetyl-D-glucosamine, engages with cellular receptors and extracellular matrix components to regulate diverse physiological and pathological processes[1][6]. Despite its structurally simple primary composition, HA exhibits remarkably complex biological activity that is regulated by multiple interdependent factors. The biological effects of HA are critically dependent on its molecular weight, with high molecular weight HA (greater than 1000 kDa) and low molecular weight HA (less than 1000 kDa) often exerting opposing effects on cellular functions[1][2]. High molecular weight HA generally promotes anti-inflammatory responses, tissue integrity, and cell proliferation, while low molecular weight HA fragments are typically associated with pro-inflammatory signaling and tissue remodeling[2]. The HA-ECM interaction operates through several key mechanisms. First, HA binds to specific cell surface receptors, most notably CD44, triggering intracellular signaling cascades including STAT3 activation that regulate cell proliferation, migration, and differentiation[3][6]. Second, HA interacts with numerous extracellular binding proteins called hyaladherins, such as TSG-6, versican, and aggrecan, which modify the structural and functional properties of the HA matrix[1]. Third, HA serves as a scaffold for other ECM components and can sequester growth factors like VEGF and TGF-β, controlling their spatial distribution and bioavailability[4]. In fibroblasts, high and medium molecular weight HA stimulates expression of genes involved in ECM deposition, including HAS1 (HA synthase), COL4A1, and COL9A1, while simultaneously downregulating matrix metalloproteinases to reduce ECM degradation[2]. This coordinated response promotes tissue repair and wound healing. HA also influences immune cell behavior, with HA-rich environments promoting M2-like macrophage polarization through CD44-mediated mechanisms[3]. The dynamic nature of HA metabolism—involving continuous synthesis by HA synthases and rapid degradation by hyaluronidases and reactive oxygen species—creates a constantly changing microenvironment that cells sense and respond to through mechanotransduction and biochemical signaling[1][4]. This makes HA-ECM interactions central to developmental processes, tissue homeostasis, injury responses, inflammation, and cancer progression.

Other names
Hyaluronan extracellular matrix interactionHA-ECM interactionHyaluronan matrix interactionHA-mediated extracellular matrix interaction
02

Mechanism of action

CD44 receptor engagement and signaling; Modulation of integrin-mediated cell adhesion; Regulation of cell proliferation through receptor activation; Extracellular matrix remodeling through metalloproteinase modulation; Growth factor sequestration and release; Mechanotransduction and force sensing; STAT3 pathway activation; TGF-β signaling modulation

03

Biological functions

Cell signaling and proliferationExtracellular matrix structural organizationTissue repair and regenerationCell migrationCell adhesionAngiogenesisInflammatory responseImmune responseWound healingTissue homeostasis
04

Disease associations

Cancer (tumor progression and metastasis)Inflammation (both pro-inflammatory and anti-inflammatory depending on molecular weight)Wound healing disordersTissue injury and repair processesImmune dysregulation
05

Safety considerations

Molecular weight-dependent opposing effects (high vs low molecular weight HA can have contradictory biological effects)Context-dependent pro-inflammatory or anti-inflammatory responsesPotential for promoting tumor progression in cancer contextsRapid degradation (half-life less than 24 hours)Potential to trigger M2-like macrophage polarization in tumor microenvironment
06

Interacting drugs

Exogenous hyaluronic acid (various molecular weights used therapeutically)

3 more in the full profile.

07

Biomarkers

CD44 expression (HA receptor)HAS1, HAS2, HAS3 expression (HA synthases)Matrix metalloproteinases (MMPs) expression levelsCollagen deposition markers (COL4A1, COL9A1, COL7A1)TIMP1 (tissue inhibitor of metalloproteinase)

Beyond the preview

Go deeper on Hyaluronic acid extracellular matrix interaction (HA-ECM interaction).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronic acid extracellular matrix interaction (HA-ECM interaction).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call